1-9 of 9
Yuki Nakajima, MD
Close
Sort by
Journal Articles

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Takuya Miyazaki, Ayako Matsumura, MD, Takayoshi Tachibana, Taiki Ando, MD, Megumi Koyama, MD, Satoshi Koyama, MD, Yoshimi Ishii, MD, Hiroyuki Takahashi, MD, Yuki Nakajima, MD, Ayumi Numata, MD, Wataru Yamamoto, MD, Kenji Motohashi, MD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD, Shin Fujisawa, MD, Hideaki Nakajima, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1976.
https://doi.org/10.1182/blood-2019-123262
Published: 2019
Journal Articles

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Taiki Ando, MD, Shin Fujisawa, MD PhD, Takayuki Sakuma, MD, Haruka Teshigawara, MD, Ayako Matsumura, MD, Taisei Suzuki, MD, Hiroshi Teranaka, MD, Akiko Negoro, MD, Eriko Ogusa, MD, Jun Aoki, MD PhD, Kazuho Miyashita, MD PhD, Yoshimi Ishii, MD PhD, Hiroyuki Takahashi, MD PhD, Yuki Nakajima, MD PhD, Takuya Miyazaki, MD PhD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD PhD, Etsuko Yamazaki, MD PhD, Hideaki Nakajima, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4562.
https://doi.org/10.1182/blood.V130.Suppl_1.4562.4562
Published: 2017
Journal Articles

Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma

Hiroshi Teranaka, MD, Shin Fujisawa, MD PhD, Takayuki Sakuma, MD, Haruka Teshigawara, MD, Ayako Matsumura, MD, Taiki Ando, MD, Taisei Suzuki, MD, Akiko Negoro, MD, Eriko Ogusa, MD, Jun Aoki, MD PhD, Kazuho Miyashita, MD PhD, Yoshimi Ishii, MD PhD, Hiroyuki Takahashi, MD PhD, Yuki Nakajima, MD PhD, Takuya Miyazaki, MD PhD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD PhD, Etsuko Yamazaki, MD PhD, Hideaki Nakajima, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5221.
https://doi.org/10.1182/blood.V130.Suppl_1.5221.5221
Published: 2017
Journal Articles

Effect of High Body Mass Index on the Prognosis of Diffuse Large B-Cell Lymphoma

Yukako Hattori, MD, Naoto Tomita, MD PhD, Taisei Suzuki, MD, Yasufumi Ishiyama, MD, Kumiko Kishimoto, MD, Satoshi Koyama, MD, Hiroyuki Takahashi, MD PhD, Kazuho Miyashita, MD, Yuki Nakajima, MD, Kenji Motohashi, MD, Hirotaka Takasaki, MD, Rika Kawasaki, MD, Chizuko Hashimoto, MD, Katsumichi Fujimaki, MD PhD, Rika Sakai, MD PhD, Shin Fujisawa, MD, Shigeki Motomura, MD PhD, Yoshiaki Ishigatsubo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5368.
https://doi.org/10.1182/blood.V124.21.5368.5368
Published: 2014
Journal Articles

Prognostic Impact of Gender in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Therapy

Hiroyuki Takahashi, MD PhD, Naoto Tomita, MD PhD, Yasufumi Ishiyama, MD, Satoshi Koyama, MD, Kazuho Miyashita, MD, Yuki Nakajima, MD, Yukako Hattori, MD, Kenji Motohashi, MD, Hirotaka Takasaki, MD, Rika Kawasaki, MD, Maki Hagihara, MDPhD, Chizuko Hashimoto, MD, Sachiya Takemura, MD, Katsumichi Fujimaki, MD PhD, Jun Taguchi, MD PhD, Rika Sakai, MD PhD, Hiroyuki Fujita, MD PhD, Shin Fujisawa, MD, Hiroshi Harano, MD PhD, Yoshiaki Ishigatsubo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5391.
https://doi.org/10.1182/blood.V124.21.5391.5391
Published: 2014
Journal Articles

No Outcome Differences Were Observed Between Supra-Diaphragmatic and Infra-Diaphragmatic Lesions in Limited-Stage Diffuse Large B Cell Lymphoma Treated with R-CHOP Therapy, Whereas the Presence of Gastro-Intestinal Lesions Was Associated with a Favorable Prognosis

Yuki Nakajima, MD, Naoto Tomita, MD PhD, Megumi Itabashi, Kazuho Miyashita, Reina Watanabe, MD, Takuya Miyazaki, MD, Takayoshi Tachibana, MD, Hirotaka Takasaki, MD, Rika Kawasaki, MD, Masatsugu Tanaka, MD, Chizuko Hashimoto, MD, Etsuko Yamazaki, MD, Jun Taguchi, MD PhD, Katsumichi Fujimaki, MD PhD, Rika Sakai, MD PhD, Hiroyuki Fujita, Shin Fujisawa, MD, Hiroshi Harano, MD PhD, Shigeki Motomura, MD, Yoshiaki Ishigatsubo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1662.
https://doi.org/10.1182/blood.V124.21.1662.1662
Published: 2014
Journal Articles

Serum Ferritin Level As a Prognostic Marker For Peripheral T-Cell Lymphoma.

Satoshi Koyama, MD, Naoto Tomita, MD, Reina Watanabe, MD, Megumi Itabashi, MD, Daisuke Ishibashi, MD, Yoshimi Ishii, MD, Yukako Hattori, MD, Yuki Nakajima, MD, Kenji Motohashi, MD, Hirotaka Takasaki, M.D., Rika Kawasaki, MD, Chizuko Hashimoto, MD, Hideyuki Koharazawa, MD, Sachiya Takemura, MD, Rika Sakai, MD, Shin Fujisawa, MD, Shigeki Motomura, MD, Yoshiaki Ishigatsubo, MD
Journal: Blood
Blood (2013) 122 (21): 4326.
https://doi.org/10.1182/blood.V122.21.4326.4326
Published: 2013
Journal Articles

Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin Lymphoma

Yuki Nakajima, MD, Naoto Tomita, MD, Reina Watanabe, MD, Yasufumi Ishiyama, MD, Eri Yamamoto, MD, Daisuke Ishibashi, MD, Megumi Itabashi, MD, Satoshi Koyama, MD, Hiroyuki Takahashi, MD, PhD, Ayumi Numata, MD, Hirotaka Takasaki, M.D., Rika Kawasaki, Hideyuki Kuwabara, MD, Masatsugu Tanaka, MD, Chizuko Hashimoto, MD, Katsumichi Fujimaki, MD, Rika Sakai, MD, Shigeki Motomura, MD, Yoshiaki Ishigatsubo, MD
Journal: Blood
Blood (2013) 122 (21): 4239.
https://doi.org/10.1182/blood.V122.21.4239.4239
Published: 2013
Journal Articles

MIB-1 Labeling Index As a Prognostic Factor in Patients with Follicular Lymphoma Treated with R-CHOP Therapy

Eri Yamamoto, MD, Naoto Tomita, MD, Seiji Sakata, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD, Yuki Nakajima, MD, Kazuho Miyashita, MD, Takayoshi Tachibana, MD, Hirotaka Takasaki, MD, Masatsugu Tanaka, MD, Chizuko Hashimoto, MD, Hideyuki Koharazawa, MD, Katsumichi Fujimaki, MD, Jun Taguchi, MD, Hiroshi Harano, MD, Shigeki Motomura, MD, Yoshiaki Ishigatsubo, MD
Journal: Blood
Blood (2012) 120 (21): 1561.
https://doi.org/10.1182/blood.V120.21.1561.1561
Published: 2012